Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia

Benzer Materyaller

• Changes in Common Blood Parameters After Discontinuation of Tyrosine Kinase Inhibitors for Chronic Myeloid Leukaemia
  Yazar:: Fiona Fernando, ve diğerleri
  Baskı/Yayın Bilgisi: (2025-10-01)
• Molecular Response of Chronic Myeloid Leukaemia Patients to Tyrosine Kinase Inhibitors
  Yazar:: Md. Imran Hossain, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-05-01)
• Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
  Yazar:: Sarah Allegra, ve diğerleri
  Baskı/Yayın Bilgisi: (2023-09-01)
• Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors
  Yazar:: Yuriko Nishiyama-Fujita, ve diğerleri
  Baskı/Yayın Bilgisi: (2022-12-01)
• Prolonged treatment-free remission in chronic myeloid leukemia patients with previous BCR-ABL1 kinase domain mutations
  Yazar:: Simone Claudiani, ve diğerleri
  Baskı/Yayın Bilgisi: (2020-05-01)